The objective of this study was to investigate whether the use of a silver-containing hydrofiber dressing to pack abscess cavity after incision and drainage (I & D) leads to faster wound healing and less pain.
Patients 18 years or older visiting the emergency department with cutaneous abscesses, requiring I & D, were randomly assigned to the intervention (Aquacel Ag; ConvaTec, Skillman, New Jersey) or standard care (iodoform) group between April 2008 and May 2009. Patients were followed up 48 to 72 hours and 10 to 14 days after the initial visit. Primary outcomes were the proportion of patients with greater than 30% reduction in surface area of abscess or cellulitis at first follow-up.
Ninety-two patients were enrolled prospectively and randomly assigned to the Aquacel Ag or the iodoform groups; mean age was 38.0 (SD, 12.0) years; 49 patients were in the Aquacel Ag and 43 were in iodoform groups, respectively. There were no differences in demographic and clinical characteristics between groups. Logistic regression analysis showed that the intervention (Aquacel Ag) was independently associated with greater than 30% reduction in surface area of abscess (P = .002) but not in cellulitis at first follow-up. There was also significant decrease in pain intensity perceived by patients in the Aquacel Ag group based on the mean change in Facial Pain Scale scores between the initial visit and first follow-up.
In patients with cutaneous abscesses, use of an antimicrobial hydrofiber ribbon dressing for packing was associated with faster wound healing and reduction in perceived pain in comparison with use of iodoform dressing.
The authors investigate whether the use of a silver-containing hydrofiber dressing to pack abscess cavity after incision and drainage leads to faster wound healing and less pain.
Victoria Alimov, MD, MPH, is Emergency Physician, Department of Emergency Medicine, Maricopa Medical Center, Phoenix, Arizona.
Frank Lovecchio, DO, MPH, is Vice Chairman, Department of Emergency Medicine, Maricopa Medical Center, Phoenix, Arizona.
Madhumita Sinha, MD, MHSM, is Attending Physician, Department of Pediatrics, Arizona Children’s Center at Maricopa Medical Center, Phoenix, Arizona.
Kevin N. Foster, MD, MBA, FACS, is Director, Arizona Burn Center, and Director of Surgical Research, Department of Surgery, Maricopa Integrated Health System, Phoenix, Arizona.
David Drachman, PhD, is Senior Biostatistician, Department of Research, Maricopa Integrated Health System, Phoenix, Arizona.
Drs Alimov, Sinha, and Drachman have disclosed that they have no financial relationships related to this article. Dr Lovecchio has disclosed that he is the recipient of grant/research funding from the National Institutes of Health and is a member of the speaker’s bureau for Forest Pharmaceuticals. Dr Foster has disclosed that he is/was a consultant advisor to Baxter Pharmaceuticals and is/was a member of the speaker’s bureau for ZymoGenetics.
This study was supported by The House Staff Achievement Grant awarded to Dr Alimov by the Maricopa Medical Foundation.
Submitted March 29, 2012; accepted in revised form July 27, 2012.